A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

Plebanek, Michael P., Xue, Yue, Nguyen, Y-Van, DeVito, Nicholas C., Wang, Xueying, Holtzhausen, Alisha, Beasley, Georgia M., Theivanthiran, Balamayooran +1 more·2024·Science Immunology

Cited by (164)

Items 101–164 of 164

  1. Lactic acid induces dendritic cell pyroptosis through MCT-1 to promote tumor immune evasion
    Shengrui Yang, Liyuan Lin, Xiang Zheng, Li J, Rong Qin, Yuqing Wu, Jian Xu · 2026 · Oncogene
  2. Lactate as a Signaling Molecule in the Tumor Microenvironment: Implications for Cancer Progression
    Shireen S. Kamil, Alaa Shahid Jassim Al-Bdery, Ali Hussein AL-Marzoqi, Hussein T. Abdulabbas, Ameer Jabir Shakir · 2026 · Biochemical Genetics
  3. Lysine lactylation‐mediated post‐translational modification: Molecular mechanisms and therapeutic target exploration in tumour drug resistance
    Juan Li, Yan Shang, Haojie Wu, S Y Yang, Maiqun Zuo, Hailong Zhao · 2026 · Clinical and Translational Medicine
  4. Lactate‐Driven Restriction of Mitochondrial Permeability Transition Promotes Resistance to Chemo‐Immunotherapy by Suppressing Tumor PANoptosis
    Sen Zhong, Wenlong Chen, Fanglong Liu, Shengyi Zhou, Bolin Yu, Yuying Wang, Xiqian Zhou, Xuehui Wang, Diya Liu, Zhuoyu Zhang et al. · 2026 · Advanced Science
  5. Metabolic reprogramming networks in the gastric cancer tumor microenvironment: an integrated axis of nutrient competition, metabolic crosstalk, and immunosuppression
    Xiaona He, Jun Liu, Wenjie Wang · 2026 · Frontiers in Immunology
  6. Cancer stem cell plasticity: mechanisms, immune microenvironment crosstalk, and therapeutic implications
    Jingyu Tan, Tao Wen, J S Liu, Xiaoli Ru · 2026 · Journal of Hematology & Oncology
  7. Lactate metabolism and protein lactylation in inflammatory and tumor microenvironments
    Huaqing Lei, Yulin Bai, Jiaqi Tang, Xiaoyan Pu, Jiarui Lan, Xiangyu Lei, Dan Cai, Shuang Gou, Lin Liu, Siyu Hao et al. · 2026 · Molecular Biomedicine
  8. Lactylation-related immune-metabolic dysregulation defines prognostic and therapeutic stratification in lung adenocarcinoma
    Meng Wang, Han Zhang, Qiuqiao Mu, Yuhang Jiang, Yuhang Wang, Kai Wang, Xin Li, Daqiang Sun · 2026 · Translational Oncology
  9. Lung DC‐T immunity hub in immune surveillance: new concepts and future directions
    Juan Liu, Boyi Cong, Xuetao Cao · 2024 · 癌症:英文版
  10. Farnesyl pyrophosphate modulates dendritic cell migration in lupus autoimmunity
    2024 · Nature Metabolism
  11. Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways
    Sophie Janssens, Sofie Rennen, Victor Bosteels, Clint De Nolf, Karo Van Lil, Sandra Maréchal, Jessica Vetters, Evelien Van De Velde, Farzaneh Fayazpour, Ria Roelandt et al. · 2024 · Research Square
  12. Generation of Activated CD8 + Tissue-Resident Memory T Cells Requires Cross-Priming by CLEC9A + Dendritic Cells During Psoriatic Chronicity
    Yun Luo, Xiaoyan Wu, Leying Liu, Changxu Han, Pengfei Song, Jian Zhang, Martin Man Ho Chung, Si Chen, Zhenying Zhang · 2025 · SSRN Electronic Journal
  13. ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity
    Benjamin Jenkins, Yasmin R Jenkins, Fernando M. Ponce-Garcia, Chloe Moscrop, Iain A. Perry, Matthew D. Hitchings, Alejandro Huerta Uribe, Federico Bernuzzi, Simon Eastham, J. Cronin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Single cell RNA sequencing reveals a dysbalance of proinflammatory vs. immunosuppressive dendritic cells in mouse and human aortic aneurysms
    Y. Ran, Jing-Pu Zhu, Ting Sun, Yi-Xin Zhang, C. Zhang, Yu-Tao Li, Zhipeng Li, Shu Wang, Li-Ping Li, Jun-Jie Zheng et al. · 2025 · Frontiers in Cardiovascular Medicine
  15. SREBP2-RAB11A-ZDHHC20 axis orchestrates FGFR3 palmitoylation and membrane retention to drive bladder cancer progression
    Wenwen Zhang, Hao-ran Qu, Xuan-shuang Du, Sujuan Sun, Pinru Chen, Zi-han Deng, Qin Pan, Feng-ling Luo, Hong-yan Wu, C. Song et al. · 2026 · Cellular Oncology
  16. Identification of prognostic genes associated with tolerogenic dendritic cells in gastric cancer based on transcriptomic data
    Shenyu Luo, Guozhi Yang, Yuhua Yuan, Yong Zhang (5893), Yihua Kang, Zhengrong Wen, wei liu, Ying Liu · 2026 · PLoS ONE
  17. Metabolic Checkpoints and Lymphoid Neogenesis in Lung Dendritic Cells: Mechanisms Guiding Tolerance and Chronic Lung Inflammation
    D.C. Fonseca Balladares, Gabriela Oliveira Siqueira Costa, Kevin Nolan, Michael H. Lee, Thaís C. F. Menezes, Brian B. Graham, Claudia Silva Mickael · 2026 · International Journal of Molecular Sciences
  18. Remise en question de la procédure de perfusion pulmonaire ex vivo par modification du liquide de perfusion avec dialyse continue dans un modèle porcin
    Julien De Wolf · 2024
  19. SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram
    Jiali Qiu, Lei Cao, Sensheng Bi, Pengyu Han, Zhenglu Wang · 2026 · BioMed Research International
  20. The resilient subset: cancer stem cells at the core of immunotherapy resistance
    Julián A. Gajón, Diego Esperante, Nahuel Ko, Aaron Jimenez-Miranda, Samira Muñoz-Cruz, Ezequiel M. Fuentes‐Pananá, Laura C. Bonifaz · 2025 · Immunotherapy Advances
  21. Tumor‐Infiltrating mregDCs Restrain Anti‐Tumor Immunity in Early Relapse HCC
    Zefan Zhang, Lin Ding, Yu Zhong, Haokang Feng, Linglong Huang, Waidong Huang, Chunqing Wang, Arne Östman, Beili Wang, Jian Zhou et al. · 2026 · Advanced Science
  22. Roles of lactate and lactylation in tumor immune suppression and drug resistance
    Jiaqi Li, Wangji Yang, Tian Xin, Zhaokai Zhou, Xiaoyu Liu, Pei Tang, Junsha An, Bin Ma, Fu Peng · 2026 · Frontiers in Immunology
  23. Rhein suppresses lactate metabolism and melanoma progression via downregulating LDHA/H3K18 lactylation/PLK1 axis
    Shuo Zheng, Shang Wang, Jia Zhu, Xintong Kui, Chunhao He, Wei Wei, Jingrong Lin, Chuanchun Han · 2026 · Journal of Advanced Research
  24. Omnipresent Lactate: Normalization of the Tumor Microenvironment as a Prerequisite for Any Anticancer Therapy
    Khava S. Vishnyakova, X. Pan, Yegorov Y.E · 2026 · Molecular Biology
  25. Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts
    Anne Sophie Hartz, Lin Li, Hazal Aslan Rejeski, Elena Pepeldjiyska, Elias Rackl, Tobias Baudrexler, Peter Bojko, Jörg Schmohl, Andreas Rank, C Schmid et al. · 2026 · Biomedicines
  26. Nanomedicine delivery systems of natural products from herbal medicine for tumor metabolic blockade
    Lianghao Yuan, Yue Zeng, Xuejun Wang, Rongchen Mao, Dan Li, Qingqing Chai, Ye Gu, Tao Sun, Aixue Li, J Z Liu · 2026 · Chinese Chemical Letters
  27. Targeted Stimulation of Dendritic Cells via MDK-ALK -STAT3 Inhibition by Dendritic Cell-derived Exosomes
    Guyue Ren, Xiaoyan Zheng, Xinchun Zou, Haoyv Zuo · 2026 · BIO Web of Conferences
  28. Metabolic regulation of dendritic cell in immunity and disease
    Dandan Han, Jianru Chen, Juan Liu · 2026 · Current Opinion in Endocrine and Metabolic Research
  29. Lactate and lactylation in hepatocellular carcinoma: A new frontier in metabolic–epigenetic interactions
    Chen Chen, Yangyang Miao, Songsong Fan, Chengji Tang, Rui Peng, J B Zhang, Jun Cao, Chi Zhang, Dousheng Bai · 2026 · Medical Oncology
  30. DC-intrinsic SHP1 restrains central memory CD8⁺ T cell formation via the TCF-1/Wnt/β-Catenin axis
    Bing Li, Huilin Lu, Jiayi Huang, Yusheng Liang, Weize Yu, Shunhong Wu, Ting Lei, Xiaoming Tan, Yu Zhang · 2026 · Medical Oncology
  31. Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
    Daniel Lu, Tao Osgood, Shining Ma, Huajia Zhang, Matt Kanke, Jessica A. Tan, Siddhi Nath Paudel, Hong Zhou, Juan Estrada, Tracy Yamawaki et al. · 2026 · Cancer Immunology Research
  32. Advances in Immunotherapy for Intrahepatic Cholangiocarcinoma
    Huimin Qi, Jialin Pan, Hailong Wu · 2026 · International Journal of Molecular Sciences
  33. Trimodal, uncertainty-guided whole-slide framework for genome-scale spatial expression and image-only virtual perturbation in cancer cohorts
    Zijun Wang, Chongyi Yang, Xiaoya Tang, Enzhi Yin, Yuxin Yao, Yuejun Luo, Jie He, Nan Sun · 2026 · Genome Medicine
  34. Lactate-driven metabolic–epigenetic reprogramming in breast cancer: immune evasion and therapeutic resistance
    Lei Sun, Li Wang, Wanqin Zeng, Shiyan Zeng · 2026 · Clinical Epigenetics
  35. Acoustic cavitation-adaptively amplified ZIF nanocomplexes for synergistic immunotherapy of colorectal cancer
    X Xu, Xiaokai Chi, Weijing Li, Jiaren Zhang, Jianwen Fang, Jingqi Sun, Shuyuan Tian, Hong Yu, W-Z Chen · 2026 · Chemical Engineering Journal
  36. MCT4-mediated lactate efflux promotes STING-dependent dendritic cell antitumor immunity
    Rui Ding, Yaqing Yuan, Tongchang Xu, Jingwen Zhang, Yi Zhu, Bing Yao, Shuang Qu, Zhilin Hu · 2026 · Cell Reports
  37. Comprehensive transcriptomic profiling uncovers an inflammatory maturation program conserved in human and mouse dendritic cells
    Jessica Bourque, Robert Kousnetsov, Daniel Hawiger · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Research and advances in TK1-mediated metabolic reprogramming in modulating the tumor immune microenvironment in hepatocellular carcinoma
    Hao Chai, Lang Wu, Minghao Li · 2026 · Discover Oncology
  39. Integrating Bulk and Single-Cell RNA Sequencing Identifies and Validates Lactylation-Related Signatures in Acute Kidney Injury
    Heping Niu, Zhendong Tian, Ziyi Li, Shujun Shi, Rongrong Deng, Jiangwei Man, Xiaochun Zhou, Li Huang, Jianqin Wang · 2026 · Biomedicines
  40. Metabolic reprogramming via LDHB confers resistance to lactate-induced dysfunction and enhanced antitumor activity in hiPSC-Derived NK cells
    Zhishuai Zhang, Yuchan Mai, Jun Tang, Jiaying Ning, Yanjiao Qin, Jiaming Gu, Zhaozong Cao, Jian Liu, Tiancheng Zhou, Junwei Wang et al. · 2026 · Stem Cell Reports
  41. Expression of LDHA, Pan-Kla Level and H3K18la associates with clinical progression of laryngeal squamous cell carcinoma
    Yangbingyu Wen, Miaolong Lu, Mu Yang, Yu Kang, Songqing Fan, Yuting Zhan · 2026 · Diagnostic Pathology
  42. 25 Years of Cancer Immunoediting: Dendritic Cells and Macrophages Filled the Missing Gap
    Vijay Kumar, John H. Stewart · 2026 · Cancers
  43. Emergence of glycolysis-lactate-Lactylation Axis in breast cancer: Mechanisms, tumour progression, and therapeutic implications
    Ishika Tyagi, Sonali Sundram, Sathvik Belagodu Sridhar, Javedh Shareef, Tarun Wadhwa, Daniel Arockiam, Rishabha Malviya · 2026 · Cellular Signalling
  44. Spatiotemporal control of mitoribosome-mediated metabolic reprogramming in cancer: implications for heterogeneity and therapeutic targeting
    Xiaojie Chen, Weidong Wang, Fangxin Shen, Zhiwei Zhao · 2026 · Frontiers in Cell and Developmental Biology
  45. Cellular and microenvironmental functions of SNHG lncRNAs in tumor immune remodeling
    Tareq Nayef AlRamadneh, Afaq Mahdi Ali, Fatima Muhammad Yunus, Pareshkumar N. Patel, K. Jamuna, Vandana Tripathi, Priya Priyadarshini Nayak, Navin Kumar Tailor · 2026 · Tissue and Cell
  46. Biodegradable Biomimetic Nanoplatform Orchestrating an Oxygen–Lactate Cascade to Enhance Photothermal Immunotherapy
    Shuo Gao, Yu Chen, Yan‐Xi He, Cong‐Min Huo, Hui‐Yu Cen, Si‐Ye Tong, Rui Huang, Chen Luo, Houjuan Zhu, Wei Xue et al. · 2026 · Advanced Healthcare Materials
  47. The Cancer Cell Metabolic Reprogramming Remodels the Tumor Microenvironment: Molecular Mechanisms and Therapeutic Strategies
    guoqing Xiang, Zhicheng Zhou, Xue Jiang, Zhenguang Du, Yangyang Zhan, Xinli Liu · 2026 · Advanced Science
  48. The neuro-immune axis in cancer: mechanisms of neural regulation of immunity within the tumor microenvironment to promote cancer progression
    Zhifan Ran, Chenghong Zeng, Jinli Han, Xinfeng Yu · 2026 · Frontiers in Immunology
  49. Nidogen 1-enriched extracellular vesicles drive HCC progression by inducing mregDC differentiation and Treg infiltration
    Lu Xia, Tingmao Xue, Yining Xu, Judy Wai Ping Yam, Xiaowen Mao · 2026 · Extracellular Vesicles and Circulating Nucleic Acids
  50. Lactylation Remodels Tumorigenesis, Immune Microenvironment, and Therapeutic Response
    Yufei Liu, Yutong Zhou, Huiwen Xue, Ruiru Xu, Y. Liu · 2026 · Current Issues in Molecular Biology
  51. Immune metabolic reprogramming in MASLD
    Joanna Razafiarison, Nicolas Venteclef, Florent Ginhoux, Camille Blériot · 2026 · JHEP Reports
  52. Metabolic reprogramming of myeloid antigen-presenting cells in the tumor microenvironment: mechanisms of antigen presentation failure and therapeutic opportunities
    Peishan Zhou, Yicun Han, Qing Ji · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  53. Radiotherapy for overcoming immune checkpoint inhibitor resistance in esophageal squamous cell carcinoma
    Changjiang Du, Yuanfei Li · 2026 · Frontiers in Immunology
  54. Immune remodeling of tumor-draining lymph nodes: mechanistic determinants of checkpoint blockade responsiveness
    Caiyan Jia, Shuxuan Li, Muhua Chen, Wuxia Yang, Yanqi Song, Aidi Wang, Baoshan Liu · 2026 · Frontiers in Immunology
  55. Metabolite-driven dysfunction of intratumoral tertiary lymphoid structures: single-cell and spatial omics perspectives on cancer immune escape
    Yifeng Wang, Yan Li, Shujuan Wei, Shengguang Ding · 2026 · Frontiers in Immunology
  56. Lactate and lactylation in cancer: metabolic regulation, immune modulation, and therapeutic opportunities
    Jiayi Chen, Anqi He, Siyi Zhu, Yong Xia, Lin Yang · 2026 · The Journal of Pathology
  57. From cold to hot: the immunomodulatory framework of Saikosaponin D in hepatocellular carcinoma therapy
    Xiaoyue Huang, Lin Liu, Meihui Qin, Runyue Liu · 2026 · Frontiers in Immunology
  58. Pimozide enhances antigen cross-presentation and promotes cytotoxic CD8+ T cell immunity by stimulating dendritic cells
    Luz María Palacios, Nicolás Daniel Dho, Cintia L. Araujo Furlan, Guadalupe López Menichetti, Federico Ruiz Moreno, Laura Guantay, Sofía Daiana Castell, María Esperanza Felici, Gastón Soria, Belkys Angélica Maletto et al. · 2026 · Frontiers in Immunology
  59. Innate immune cells in tumor immunity: dual roles, mechanistic insights, and therapeutic opportunities
    Songhang Xing, 张佳宇, Shuang Wang, Yuan Hao, Dan Huang, Manwei Hao, Wurihan Bao, Xiaojie Qu, Yanyan Chi, Xuefeng Li · 2026 · Frontiers in Immunology
  60. Nanomedicine strategies for overcoming cellular and microenvironmental barriers to cuproptosis-based cancer therapy
    Lei Ge, Dong Wang, Ben Zhong Tang · 2026 · Journal of Controlled Release
  61. Engineered mitochondria-derived vesicles suppress colorectal cancer through metabolic reprogramming and mtDNA–cGAS–STING signaling
    Ziqi Zhang, Zi Yan, Suiqing Huang, Xiaozhi Yang, Qingshi Wang, Junhai Huang, Haihao Wang, Yuxian Du, Tianxiang Qi, Liubing Hu et al. · 2026 · Cellular Signalling
  62. Targeted lactate depletion via gluconeogenesis by engineered hepatocyte-based micronanorobots for radiosensitization and immune activation
    Yueyue Fan, Jiamin Ye, Yuanfang Chen, Gaoli Niu, Mengbin Ding, Ruiyan Li, Li Wang, Yong Kang, Xiangyang Yu, Xiaoyuan Ji · 2026 · Cell Reports Medicine
  63. Redox-responsive nanoparticles prevent post-ablation hepatocellular carcinoma recurrence by dual regulation of dendritic cells and tumor cells
    Man Luo, Sui Zheng, Wanrong Luo, Yixin Zhang, Liu Rongbin, Zhibin Shen, Yingshi Zhou, Jiabao Tan, Xiaoqing Su, Yan Cai et al. · 2026 · Journal of Controlled Release
  64. Targeting Dendritic Cells in Cancer Immunotherapy: From Immune Priming to Tumor Microenvironment Reprogramming
    Serena Zanotta, Domenico Galati · 2026 · International Journal of Molecular Sciences